Lucid Diagnostics (LUCD) Enterprise Value (2020 - 2026)

Lucid Diagnostics has reported Enterprise Value for 7 years, with the latest figure at -$27.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 10.45% year-over-year to -$27.9 million; the trailing twelve-month figure through Mar 2026 stood at -$27.9 million (down 10.45% YoY), and the FY2025 full-year result was -$34.7 million, down 55.22% from the prior year.
• Enterprise Value for Q1 2026 stood at -$27.9 million, up from -$34.7 million in the prior quarter.
• The five-year high for Enterprise Value was -$14.5 million in Q3 2024, with the low at -$47.9 million in Q1 2022.
• Historically, Enterprise Value has averaged -$29.3 million across 5 years, with a median of -$26.9 million in 2022.
• The largest YoY upside for Enterprise Value was 58.11% in 2022 against a maximum downside of 126137.35% in 2022.
• Lucid Diagnostics' Enterprise Value stood at -$22.5 million in 2022, then climbed by 15.92% to -$18.9 million in 2023, then slipped by 18.32% to -$22.4 million in 2024, then plunged by 55.22% to -$34.7 million in 2025, then gained by 19.68% to -$27.9 million in 2026.
• The last three Enterprise Value figures came in at -$27.9 million (Q1 2026), -$34.7 million (Q4 2025), and -$47.3 million (Q3 2025), per Business Quant data.